Registration
SQUIRE PATTON BOGGS for HEMISPHERX BIOPHARMA, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Foreign Relations FOR
Investigational New Drug (IND) designation
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARYN FAYE FRIDERES New | — |
| ROBERT KAPLA New | SpAsPACounEQPres97-99;SpAsssCounEQPres96-97 |
| EDWARD J. NEWBERRY New | — |
| KEVIN O'NEILL New | — |
| STUART MICHAEL PAPE New | — |
Pharmacy PHA
Investigational New Drug (IND) designation
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARYN FAYE FRIDERES New | — |
| ROBERT KAPLA New | SpAsPACounEQPres97-99;SpAsssCounEQPres96-97 |
| EDWARD J. NEWBERRY New | — |
| KEVIN O'NEILL New | — |
| STUART MICHAEL PAPE New | — |
Medical/Disease Research/Clinical Labs MED
Investigational New Drug (IND) designation
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARYN FAYE FRIDERES New | — |
| ROBERT KAPLA New | SpAsPACounEQPres97-99;SpAsssCounEQPres96-97 |
| EDWARD J. NEWBERRY New | — |
| KEVIN O'NEILL New | — |
| STUART MICHAEL PAPE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.